THE USE OF ONCOFETAL FERRITIN-BEARING LYMPHOCYTES AS A MARKER FOR THE SCREENING, DIAGNOSIS, AND FOLLOW-UP OF PATIENTS WITH EARLY BREAST MALIGNANCY SCREENING OF 3400 WOMEN

被引:0
作者
MOROZ, C
KAHN, M
RON, E
LURIA, H
CHAIMOFF, C
机构
[1] BEILINSON MED CTR,DEPT ONCOL,IL-49100 PETACH TIKVA,ISRAEL
[2] TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL
[3] TEL AVIV UNIV,HASHARON HOSP,DEPT SURG A,IL-69978 TEL AVIV,ISRAEL
[4] CHAIM SHEBA MED CTR,DEPT CLIN EPIDEMIOL,IL-52621 TEL HASHOMER,ISRAEL
[5] NCI,RADIAT EPIDEMIOL BRANCH,BETHESDA,MD 20205
关键词
D O I
10.1002/1097-0142(19890801)64:3<691::AID-CNCR2820640321>3.0.CO;2-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:691 / 697
页数:7
相关论文
共 31 条
[1]  
Abramson JH, 1983, CALCULATOR PROGRAMS
[2]   PROGRESS AGAINST CANCER [J].
BAILAR, JC ;
SMITH, EM .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (19) :1226-1232
[4]  
Breslow NE, 1980, IARC SCI PUBLICATION, V32
[5]  
CHELADA A, 1982, B CANCER PARIS, V69, P22
[6]  
CHERNOVSKAIA EM, 1986, MED RADIOL MOSK, V3, P17
[7]  
COLETTE HJA, 1984, LANCET, V1, P1224
[8]  
DESOUSA M, 1976, IMMUNOPATHOLOGY LYMP, P393
[9]  
FEREBERGER W, 1984, WIENER MED WSCHR S79, V134, P1
[10]  
FRANKL G, 1983, RADIOL CLIN N AM, V21, P81